Medical device supplier Taiwan Biomaterial Co (台生材) is counting on two new devices — the foamy gun and the stroke interventional device — to drive growth as they could address unmet clinical needs, while the company hopes to turn a profit within three years, chief executive officer Liao Chun-jen (廖俊仁) said yesterday.
The US Food and Drug Administration (FDA) in April granted Taiwan Biomaterial marketing approval for the stroke interventional device, which can help doctors remove blood clots from the brain, Liao said.
For people who had an ischemic stroke, the physical removal of the blockage would help them recover better than clot-busting drugs, Liao said, adding that it has proved to work the best within six hours after a stroke.
The device has great potential as few companies produce it, he said.
Taiwan Biomaterial plans to cooperate with US medical company Incept LLC to manufacture the device and market it in the US this year, he said.
The company last year also gained marketing approval for its foamy gun from Taiwanese regulators, he said.
The device, which produces a highly porous foamy gel made out of collagen mixed with high-pressure gas, can be used for dura reconstruction after surgeries, he said.
The company is in talks with the local regulator to see if it could be included in the public health insurance program, which would mean adopting a different marketing strategy, he said.
“If we join the [public health insurance] program, more patients are likely to use the gun, but the selling price per gun would be lower than if we stick to the self-pay system. We are still in the process of deciding whether to join the program or not,” Liao said.
The company reported a net loss of NT$60.54 million (US$1.93 million) for last year, or minus-NT$2.02 per share.
In the first quarter of this year, it posted a net loss of NT$17.07 million, or minus-NT$0.57 per share.
The company, which first traded on the Emerging Stock Board in August 2017, made its debut on the Taipei Exchange (TPEX) yesterday.
With a listing price of NT$42, Taiwan Biomaterial shares surged 15 percent to close at NT$48.3, TPEX data showed.
The company, which focuses on the development of implantable medical devices, was spun off from the Industrial Technology Research Institute (工研院) seven years ago.
Like another pharmaceutical firm, EirGenix Inc (台康生技), Taiwan Biomaterial won approval thanks to a recommendation letter from the Industrial Development Bureau, which allowed it to bypass some listing requirements on sales, earnings and cash flow.
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to